发明名称 Papillomavirus E2 trans-activation repressors
摘要 This invention relates to E2 trans-activation repressors which interfere with normal functioning of the native full-length E2 transcriptional activation protein of the papillomavirus. Native full-length E2 trans-activation protein activates transcription of papillomavirus only through binding to DNA, and it binds to DNA only in the form of a pre-formed homodimer-a pair of identical polypeptide subunits held together by non-covalent interactions. The E2 trans-activation repressors of this invention are proteins, polypeptides or other molecules that dimerize with full-length native E2 polypeptides to form inactive heterodimers, thus interfering with the formation of active homodimers comprising full-length native E2 polypeptides, thereby repressing papillomavirus transcription and replication. The E2 trans-activation repressors of this invention are advantageously used in the treatment of papillomavirus infections and their associated diseases.
申请公布号 US5667965(A) 申请公布日期 1997.09.16
申请号 US19950455972 申请日期 1995.05.31
申请人 BIOGEN, INC.;NEW ENGLAND MEDICAL CENTER HOSPITALS, INC. 发明人 ANDROPHY, ELLIOT J.;BARSOUM, JAMES G.
分类号 A61K38/00;A61P31/12;C07K14/025;C07K14/16;C12N1/19;C12N1/21;C12N15/09;C12N15/37;C12P21/02;C12R1/19;C12R1/85;(IPC1-7):C12P21/06;C12Q1/70;C12N7/00;C12N7/02 主分类号 A61K38/00
代理机构 代理人
主权项
地址